These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10985880)

  • 1. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.
    Bertelli G; Valenzano M; Costantini S; Rissone R; Angiolini C; Signorini A; Gustavino C
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):275-7. PubMed ID: 10985880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen.
    Elhelw B; Ghorab MN; Farrag SH
    Int J Gynaecol Obstet; 1999 Nov; 67(2):81-6. PubMed ID: 10636051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.
    Cohen I
    Gynecol Oncol; 2001 Aug; 82(2):406-7. PubMed ID: 11531305
    [No Abstract]   [Full Text] [Related]  

  • 4. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
    Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
    Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
    Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
    J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients.
    Tepper R; Beyth Y; Altaras MM; Zalel Y; Shapira J; Cordoba M; Cohen I
    Gynecol Oncol; 1997 Mar; 64(3):386-91. PubMed ID: 9062139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.
    Fung MF; Reid A; Faught W; Le T; Chenier C; Verma S; Brydon E; Fung KF
    Gynecol Oncol; 2003 Oct; 91(1):154-9. PubMed ID: 14529676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
    Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
    AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
    McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
    Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the progesterone test in screening for endometrial pathology in asymptomatic postmenopausal women receiving treatment with tamoxifen.
    Lubian López DM; Fernandez YG; Rodríguez BR; López FM; Delgado RC
    Menopause; 2010; 17(3):487-93. PubMed ID: 20464783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen.
    Schwartz LB; Snyder J; Horan C; Porges RF; Nachtigall LE; Goldstein SR
    Ultrasound Obstet Gynecol; 1998 Jan; 11(1):48-53. PubMed ID: 9511196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
    Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
    Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patients.
    Cohen I; Perel E; Flex D; Tepper R; Altaras MM; Cordoba M; Beyth Y
    J Clin Pathol; 1999 Apr; 52(4):278-82. PubMed ID: 10474520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
    Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
    Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients.
    Markovitch O; Tepper R; Fishman A; Shapira J; Aviram R; Cohen I
    Gynecol Oncol; 2004 Dec; 95(3):456-62. PubMed ID: 15581946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium.
    Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S
    J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
    Hann LE; Gretz EM; Bach AM; Francis SM
    AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of endometrium during tamoxifen therapy of breast cancer].
    Obrebowska A; Sibila-Owczarska A; Sajdak S
    Ginekol Pol; 2002 Nov; 73(11):1109-12. PubMed ID: 12722407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of sonohysterography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients.
    Markovitch O; Tepper R; Aviram R; Fishman A; Shapira J; Cohen I
    Gynecol Oncol; 2004 Sep; 94(3):754-9. PubMed ID: 15350369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
    Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
    Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.